These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2585617)

  • 21. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
    Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Cancer; 1994 Nov; 74(10):2819-27. PubMed ID: 7954243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of locally advanced carcinoma of the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone].
    Smith JA; Crawfort ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW
    Urologe A; 1998 Sep; 37(5):532-3. PubMed ID: 9796037
    [No Abstract]   [Full Text] [Related]  

  • 24. The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia.
    Mameghan H; Fisher RJ; Watt WH; Meagher MJ; Rosen IM; Mameghan J; Brook S; Tynan AP; Korbel EI; Millard RJ
    Cancer; 1992 Jun; 69(11):2771-8. PubMed ID: 1571908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years.
    Bessell EM; Taylor J; Moloney AJ; Lemberger J
    Radiother Oncol; 1993 Dec; 29(3):344-6. PubMed ID: 8127986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose.
    Whillis D; Howard GC; Kerr GR; Fowler J; Hargreave TB; Chisholm GD
    J R Coll Surg Edinb; 1992 Feb; 37(1):42-5. PubMed ID: 1573607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.
    Vikram B; Malamud S; Silverman P; Hecht H; Grabstald H
    J Urol; 1994 Mar; 151(3):602-4. PubMed ID: 8308967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density.
    Cheng CW; Ng CF; Chan CK; Wong WS; Hui PE; Wong YF
    Int Braz J Urol; 2006; 32(5):536-49. PubMed ID: 17081322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
    Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
    Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.
    Chyle V; Pollack A; Czerniak B; Stephens LC; Zagars GK; Terry NH; Meyn RE
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):281-7. PubMed ID: 8635934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.
    Harada K; Sakai I; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Eto H; Miyake H
    Int Urol Nephrol; 2006; 38(1):49-55. PubMed ID: 16502052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.
    Moonen L; vd Voet H; de Nijs R; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):525-30. PubMed ID: 9806510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.